The Institutional Biosafety Committee (IBC) is responsible for overseeing research performed at Carleton involving recombinant and synthetic nucleic acid molecules — as defined in Carleton’s Policy and in the NIH Guidelines — in order to protect the health and safety of employees and the public.
For questions or concerns about biosafety or about the IBC at Carleton, contact Associate Dean Eric Egge, (507) 222-4301.
The “Register Your Experiment” page describes the application process for IBC approval of a research project, and for amending an existing approved registration.
For Institutional Biosafety Committee (IBC) members, and any PI and undergraduate researchers involved in recombinant DNA research: see our resources about Training and view instructions to access CITI modules.
- Carleton’s IBC Policy and Practice for Research Involving Recombinant DNA
- Carleton’s Registration Instructions and Form
- Carleton’s rDNA Registration Amendment Form
- Carleton’s form for self-assessment of exempt experiments
- National Institute of Health’s “Guidelines for Research Involving Recombinant DNA or Synthetic Nucleic Acid Molecules”